Searched for
DRUG EVALUATION
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...19 Jun, 2026, 11.50 AM IST- FDA expands recall to all Clover Hill Dairy cheeses after listeria found in products and facilityUS food safety authorities have expanded a cheese recall due to Listeria contamination, now encompassing all products from Clover Hill Dair...19 Jun, 2026, 09.04 AM IST
- Death rate in ICE immigrant detention centers more than doubles under Trump, Reuters analysis findsFifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...17 Jun, 2026, 03.38 PM IST
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...16 Jun, 2026, 10.40 AM IST
- Florida sues TikTok, claiming it violates state child safety lawThe lawsuit seeks a court order directing the platform, which is owned by ByteDance, to make changes to bring it into compliance with the l...16 Jun, 2026, 07.19 AM IST
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...15 Jun, 2026, 11.11 AM IST
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...14 Jun, 2026, 12.28 PM IST
- US stocks | Alphabet taps Intel to make three million in-house chips: ReportNvidia has not placed an order with Intel yet, but has been evaluating whether the company's technology can be used to make a processor tha...08 Jun, 2026, 10.02 PM IST
- US stocks today: US market gains as semiconductor stocks rebound, Middle East tensions easeMajor Wall Street indexes saw a strong rebound. This recovery was driven by gains in chip stocks. Signs of de-escalation in Middle East ten...08 Jun, 2026, 07.38 PM IST
- Sleeping over 8 hours daily? Senior Neurologist at Apollo Hospitals explains its underlying health issues and potential risksAre you sleeping more than 8 hours? New research has revealed that a study of nearly 500,000 people found a 'sweet spot' of 6.4 to 7.8 hour...07 Jun, 2026, 08.30 AM IST
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...06 Jun, 2026, 02.43 PM IST
- In 1937, a chemistry student tasted something sweet on a cigarette, and this led to a sweetener that changed diet foods industryA lab accident in 1937 led to the discovery of cyclamate, an artificial sweetener. It quickly became popular for low-calorie products. Late...03 Jun, 2026, 04.36 PM IST
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...03 Jun, 2026, 09.22 AM IST
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...02 Jun, 2026, 12.01 AM IST
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....01 Jun, 2026, 10.11 AM IST
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...28 May, 2026, 09.51 PM IST
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...28 May, 2026, 11.52 AM IST
Load More
